Clinical Trial: Insulin Versus Oral Hypoglycemic Agents in Gestational Diabetes Mellitus

U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07582471) titled 'Insulin Versus Oral Hypoglycemic Agents in Gestational Diabetes Mellitus' on May 06.

Brief Summary: In order to ascertain the relative safety and effectiveness of insulin and OHAs in the treatment of GDM, well-designed, prospective clinical trials are required. GDM is growing more common, and proper care is crucial to preventing complications. Although the evidence is conflicting, both therapy approaches might be beneficial. To maximize outcomes for both mother and child, evidence-based recommendations for pregnant women with GDM must close this knowledge gap. Comparing the effects of insulin and metformin in gestational diabetes mel...